Diclofenac Identified as a Kynurenine 3-Monooxygenase Binder and Inhibitor by Molecular Similarity Techniques-Reference-Cited by-同舟云学术

Diclofenac Identified as a Kynurenine 3-Monooxygenase Binder and Inhibitor by Molecular Similarity Techniques

Published:2018-03-02 Issue:3 Volume:3 Page:2564-2568
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Shave Steven¹,McGuire Kris,Pham Nhan T.¹,Mole Damian J.,Webster Scott P.,Auer Manfred¹^ORCID

Affiliation:

1. School of Biological Sciences, University of Edinburgh, The King’s Buildings, Max Born Crescent, CH Waddington Building, Edinburgh, Scotland EH9 3BF, U.K.

Funder

Medical Research Council

Scottish Universities Life Sciences Alliance

European Community?s 7th Framework Program

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.7b02091

Reference35 articles.

1. Innovation in the pharmaceutical industry: New estimates of R&D costs

2. An analysis of the attrition of drug candidates from four major pharmaceutical companies

3. Drug repurposing from the perspective of pharmaceutical companies

4. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen

5. Unlicensed and off label drug use in neonates Commentary

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Confocal Scanning Protein–Protein Interaction Assay (PPI-CONA) Reveals Exceptional Selectivity and Specificity of CC0651, a Small Molecule Binding Enhancer of the Weak Interaction between the E2 Ubiquitin-Conjugating Enzyme CDC34A and Ubiquitin;Bioconjugate Chemistry;2024-08-21

2. Tryptophan metabolism in health and disease;Cell Metabolism;2023-08

3. Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases;European Journal of Medicinal Chemistry;2023-05

4. Acute administration of ibuprofen increases serum concentration of the neuroprotective kynurenine pathway metabolite, kynurenic acid: a pilot randomized, placebo-controlled, crossover study;Psychopharmacology;2022-10-22

5. Kynurenine‐3‐monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression;Journal of Cellular Physiology;2022-09-11